Insider Trading History of Wang Xiaodong

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wang Xiaodong since 2016. This trader's CIK number is 1662982. At the time of last reporting, Wang Xiaodong was the Director of Beone Medicines Ltd.. (stock ticker symbol ONC). Also see all insider trading activities at Beone Medicines Ltd..



Yearly summary of insider trading at Beone Medicines Ltd. (ONC) by Wang Xiaodong

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ONC 0 $0 260,713 $60,857,750 250,560 $1,628,640
2024 ONC 0 $0 90,111 $17,075,055 80,221 $521,436
2023 ONC 0 $0 67,635 $15,257,982 67,635 $8,792
2022 ONC 0 $0 16,060 $3,158,274 0 $0
2021 ONC 0 $0 12,394 $4,179,508 47,503 $6,175
2020 ONC 0 $0 73,847 $16,903,266 0 $0
2019 ONC 0 $0 19,847 $3,509,783 0 $0
2018 ONC 0 $0 13,449 $1,953,970 0 $0
2017 ONC 0 $0 200,000 $8,628,249 0 $0
2016 ONC 0 $0 93,750 $3,000,000 0 $0


Insider trading of Beone Medicines Ltd. (ONC) by Wang Xiaodong

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-24 ONC Sale 2,007 265.81 533,474
2025-06-10 ONC Option Ex 41,760 6.50 271,440
2025-06-10 ONC Sale 41,760 263.10 10,987,139
2025-05-13 BGNE Option Ex 41,760 6.50 271,440
2025-05-13 BGNE Sale 41,760 224.06 9,356,703
2025-04-14 BGNE Option Ex 41,760 6.50 271,440
2025-04-14 BGNE Sale 41,760 243.52 10,169,562
2025-03-18 BGNE Sale 41,760 261.12 10,904,371
2025-03-18 BGNE Option Ex 41,760 6.50 271,440
2025-03-04 BGNE Sale 8,146 254.67 2,074,549
2025-02-04 BGNE Option Ex 41,760 6.50 271,440
2025-02-04 BGNE Sale 41,760 225.64 9,422,726
2025-01-07 BGNE Option Ex 41,760 6.50 271,440
2025-01-07 BGNE Sale 41,760 177.42 7,409,226
2024-12-10 BGNE Option Ex 41,760 6.50 271,440
2024-12-10 BGNE Sale 41,760 189.29 7,904,708
2024-11-26 BGNE Option Ex 38,461 6.50 249,996
2024-11-26 BGNE Sale 48,351 189.66 9,170,347
2023-03-08 BGNE Option Ex 67,635 .13 8,792
2023-03-08 BGNE Sale 67,635 225.59 15,257,982
2022-08-05 BGNE Sale 10,000 193.35 1,933,470
2022-08-08 BGNE Sale 6,060 202.11 1,224,804
2021-11-08 BGNE Sale 4,500 350.47 1,577,128
2021-11-08 BGNE Sale 4,500 351.11 1,580,013
2021-05-10 BGNE Sale 3,394 301.23 1,022,367
2021-05-10 BGNE Option Ex 47,503 .13 6,175
2020-10-16 BGNE Sale 5,000 320.00 1,600,000
2020-10-05 BGNE Sale 5,000 300.00 1,500,000
2020-09-25 BGNE Sale 5,000 280.82 1,404,095
2020-09-17 BGNE Sale 5,000 260.69 1,303,454
2020-08-10 BGNE Sale 4,000 212.35 849,396
2020-07-20 BGNE Sale 17,000 251.50 4,275,517
2020-07-07 BGNE Sale 6,000 200.00 1,200,000
2020-07-01 BGNE Sale 4,847 190.83 924,962
2020-06-22 BGNE Sale 5,000 181.95 909,745
2020-06-23 BGNE Sale 6,000 186.52 1,119,108
2020-06-08 BGNE Sale 6,000 171.46 1,028,730
2020-03-04 BGNE Sale 5,000 157.65 788,259
2019-11-14 BGNE Sale 11,109 193.98 2,154,901
2019-11-15 BGNE Sale 1,891 202.05 382,076
2019-11-01 BGNE Sale 1,000 170.00 170,000
2019-11-04 BGNE Sale 1,000 190.00 190,000
2019-07-01 BGNE Sale 4,847 126.43 612,806
2018-12-03 BGNE Sale 5,000 155.71 778,545
2018-11-19 BGNE Sale 5,000 124.58 622,875
2018-08-13 BGNE Sale 3,449 160.21 552,550
2017-07-12 BGNE Sale 20,000 72.49 1,449,740
2017-06-28 BGNE Sale 35,000 45.17 1,581,090
2017-06-02 BGNE Sale 5,539 40.00 221,560
2017-05-03 BGNE Sale 9,970 40.71 405,868
2017-05-04 BGNE Sale 4,491 41.01 184,171
2017-04-05 BGNE Sale 11,650 36.80 428,766
2017-03-24 BGNE Sale 18,787 36.93 693,841
2017-03-23 BGNE Sale 11,041 36.99 408,461
2017-03-22 BGNE Sale 8,279 37.75 312,515
2017-03-08 BGNE Sale 10,992 39.77 437,206
2017-03-09 BGNE Sale 18,596 39.95 742,835
2017-03-10 BGNE Sale 7,304 39.94 291,699
2017-02-23 BGNE Sale 5,505 38.57 212,349
2017-02-24 BGNE Sale 28,402 38.34 1,088,819
2017-02-27 BGNE Sale 4,444 38.10 169,329
2016-11-23 BGNE Sale 93,750 32.00 3,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wang Xiaodong (Director of Beone Medicines Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.